BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Up 79.6% in December

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 354,000 shares, an increase of 79.6% from the December 15th total of 197,100 shares. Approximately 3.0% of the company’s stock are sold short. Based on an average daily volume of 3,780,000 shares, the short-interest ratio is currently 0.1 days.

BioNexus Gene Lab Stock Performance

Shares of NASDAQ BGLC opened at $0.38 on Friday. BioNexus Gene Lab has a one year low of $0.21 and a one year high of $3.39. The business’s 50-day moving average price is $0.30 and its two-hundred day moving average price is $0.39.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.